Prevention of alterations in intestinal permeability is involved in zinc inhibition of acute ethanol-induced liver damage in mice.
Acute ethanol exposure causes liver injury in experimental animals, and accumulating evidence suggests that a major responsible factor for the pathogenesis is endotoxemia, which results from bacterial endotoxin leakage from the small intestine due to increased intestinal permeability under alcohol challenge. The purpose of this study was to examine whether zinc pretreatment would inhibit acute ethanol-induced liver injury through prevention of intestinal permeability changes. Male 129 SvPCJ mice were treated with three intragastric doses of ZnSO4 at 5 mg of zinc ion per kg each dosing prior to acute ethanol challenge with a single oral dose of 6 g/kg ethanol. The zinc treatment did not alter the elevation of serum concentrations of alcohol. The acute ethanol exposure caused an elevation in serum alanine aminotransferase levels as well as fatty liver and hepatic degenerative necrotic foci as determined by biochemical assay and histochemical analysis, respectively. A significant increase in liver tumor necrosis factor-alpha (TNF-alpha) levels was detected by enzyme-linked immunosorbent assay. These pathological effects correlated well with increases in serum endotoxin levels. Importantly, acute ethanol treatment caused significant damage to the small intestine as determined by morphological analysis of intestinal sections and permeability assay. These alcohol-induced hepatic pathological changes and TNF-alpha elevation were significantly inhibited in the zinc-pretreated animals. The inhibitory action of zinc on alcohol-induced liver damage and activation of inflammation was associated with zinc suppression of alcohol-induced intestinal permeability changes. These results thus demonstrate that zinc prevention of increased intestinal permeability is importantly involved in the inhibition of acute ethanol-induced liver damage in mice.
Lambert
Jason C
JC
Department of pharmacology and Toxicology, University of Louisville School of Medicine, Louisville, KY 40202, USA.
Zhou
Zhanxiang
Z
Wang
Lipeng
L
Song
Zhenyuan
Z
McClain
Craig J
CJ
Kang
Y James
YJ
D000818:Animals; D002492:Central Nervous System Depressants / Q000009:adverse effects / Q000097:blood*; D019446:Endotoxemia / Q000139:chemically induced; D000431:Ethanol / Q000009:adverse effects / Q000097:blood*; D007422:Intestines / Q000187:drug effects* / Q000473:pathology / Q000502:physiology; D008108:Liver Diseases, Alcoholic / Q000517:prevention & control*; D008297:Male; D051379:Mice; D010539:Permeability / Q000187:drug effects*; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism; D015032:Zinc / Q000494:pharmacology / Q000627:therapeutic use*
D002492:Central Nervous System Depressants; D014409:Tumor Necrosis Factor-alpha; D000431:Ethanol; D015032:Zinc